Key facts
- Gaia (London)’s last known valuation is $125.2M (Feb 2022).
- It has raised $38.2M; the latest was Later Stage VC ($15.0M) in Jul 2025.
- Notable investors include FJ Labs, Seedcamp, Clocktower Ventures, Atomico, Lloyd's Lab — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Gaia (London)
- ·The full record, as it builds
Funding rounds
No funding rounds for Gaia (London) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gaia (London)
Provider of medical insurance services intended to cover in vitro fertilization outcome risks. The company's service offers personalized success prediction and tailored insurance plans that combine reproductive health data with financial aspects, enabling individuals to access treatments that are more accessible and affordable and protect them from spiraling costs.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 23
- Website
- gaiafamily.com/
- Ownership
- Privately Held (backing)
Gaia (London) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gaia (London) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gaia (London) in its N-PORT filings yet. We sweep new filings monthly.